Is There a Way to Track Patient Compliance with Low Dose Naltrexone (LDN)?

Is There a Way to Track Patient Compliance with Low Dose Naltrexone (LDN)?

Tracking chart for patient compliance.  So what we're looking at is telling the patient that the target symptom is diminished, diffuse pain, and then increased energy and improved mood.  And then what we're doing is at least two weeks after establishing the maximally effective dose, present them with the same validated instruments that you used on intake to see what their change was from intake to where they are two weeks after the maximally effective dose. So that's it.  To be more compliant, you know there would be ways to do that. We're thinking of actually working with Accenture, which is helping us with artificial intelligence to do data analysis for large groups, and they have an avatar that they use for patient tracking. The Avatar asks you how they're doing today, and they seem to get a much greater response rate with some iconic figure asking for how they're doing rather than fill out this form. Hopefully, at some point, we'll be able to introduce that to our patients and to get better tracking for compliance.